New Delhi : The Delhi High Court has barred the export of generic kidney and liver cancer medication, Sorefenat, manufactured by Natco Pharma Ltd on the plea of German drug major Bayer Corporation.
Justice Manmohan, however, gave liberty to Natco to seek the court’s permission to export the drug as and when it gets the nod from the Drug Controlling Authority.
The court also issued notice to the Centre, customs authorities and Natco, seeking their replies on the plea of Bayer which has alleged that the generic drug is being made under compulsory licence for sale in India and thus, it cannot be exported.
Bayer has sought directions to the customs authorities to seize and confiscate the consignment.
Bigg Boss 19: Media Round Leaves Pranit More Under Fire, Netizens Say 'Expose His Dirty Face'
'Yellove Streets Will Never Forget...': CSK Pays Emotional Tribute As Faf Du Plessis Ends His IPL Journey After 14 Seasons
Navi Mumbai News: Rotary Club Of NaMastu Upgrades Welfare And Medical Facilities At Taloja Central Prison
Mumbai Fraud: Father–Son Trio Booked For Cheating Lawyer And Builder Of ₹1.30 Crore In Loan Scam
